PHARMA DESIGN, INC.
|PHARMA DESIGN, INC. Patent applications|
|Patent application number||Title||Published|
|20120302524||1,3,4-OXADIAZOLE-2-CARBOXAMIDE COMPOUND - Provided is a 1,3,4-oxadiazole-2-carboxamide compound which has STAT3 inhibitory activity and is useful as an anticancer agent. Provided is a 1,3,4-oxadiazole-2-carboxamide compound represented by formula (I) or a pharmacologically acceptable salt thereof (in the formula, Ar represents a furyl group or the like; R||11-29-2012|
|20110172429||STAT3 INHIBITOR CONTAINING QUINOLINECARBOXAMIDE DERIVATIVE AS ACTIVE INGREDIENT - The present invention provides a STATS inhibitor containing as an active ingredient, a quinolinecarboxamide derivative represented by the formula (I) (in the formula, W represents a bond or an alkylene chain; X represents O, S, or NR||07-14-2011|